These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2801549)

  • 61. Characteristics and clinical significance of silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with ischemic heart disease.
    Kohya T; Tomita F; Yasuda H
    Jpn J Med; 1990; 29(6):671-2. PubMed ID: 1983201
    [No Abstract]   [Full Text] [Related]  

  • 62. [Characteristics and clinical significance of silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with ischemic heart disease].
    Tomita F
    Hokkaido Igaku Zasshi; 1990 Nov; 65(6):583-94. PubMed ID: 2265819
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Attenuation of adenosine-induced myocardial perfusion heterogeneity by atenolol and other cardioselective beta-adrenoceptor blockers: a crossover myocardial perfusion imaging study.
    Reyes E; Stirrup J; Roughton M; D'Souza S; Underwood SR; Anagnostopoulos C
    J Nucl Med; 2010 Jul; 51(7):1036-43. PubMed ID: 20554740
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Silent ischemia and beta-blockade.
    Egstrup K
    Circulation; 1991 Dec; 84(6 Suppl):VI84-92. PubMed ID: 1683614
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison between metoprolol orally osmotic once daily and metoprolol two or three times daily in suppressing exercise-induced and daily myocardial ischemia.
    Tzivoni D; Medina A; David D; Barzilai Y; Gavish A; Shatboon D; Keren A; Brunel P
    Am J Cardiol; 1996 Dec; 78(12):1362-8. PubMed ID: 8970407
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of beta-blockade and atropine on ischemic responses in left ventricular regions subtending coronary stenosis during dobutamine stress echocardiography.
    Chen L; Ma L; de Prada VA; Chen M; Feng YJ; Waters D; Gillam L; Chen C
    J Am Coll Cardiol; 1996 Dec; 28(7):1866-76. PubMed ID: 8962578
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Effectiveness of various combination therapies in patients with coronary heart disease].
    Lehmann G; Reiniger G; Wolf H; Beyerle A; Rudolph W
    Herz; 1990 Dec; 15(6):399-409. PubMed ID: 1980660
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Day-to-day variability of the long-term fractal component of heart rate variability (beta) and the effect of an antianginal agent in patients with silent myocardial ischemia.
    Takase B; Akima T; Satomura K; Ohsuzu F; Mastui T; Ishihara M; Kurita A
    Biomed Pharmacother; 2004 Oct; 58 Suppl 1():S123-8. PubMed ID: 15754850
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of beta-adrenergic blocking agents on the circadian occurrence of ischemic cardiovascular events.
    Goldstein S
    Am J Cardiol; 1990 Nov; 66(16):63G-65G. PubMed ID: 1978547
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Circadian variation in myocardial ischemia: the possible mechanisms involving in this phenomenon.
    Li JJ
    Med Hypotheses; 2003 Aug; 61(2):240-3. PubMed ID: 12888312
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of beta blockade in the treatment of myocardial ischemia.
    Deedwania PC; Carbajal EV
    Am J Cardiol; 1997 Nov; 80(9B):23J-28J. PubMed ID: 9375946
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Twenty-four-hour spectral analysis of heart rate variability in congestive heart failure secondary to coronary artery disease.
    Casolo G; Balli E; Fazi A; Gori C; Freni A; Gensini G
    Am J Cardiol; 1991 May; 67(13):1154-8. PubMed ID: 1809257
    [No Abstract]   [Full Text] [Related]  

  • 73. Increased demand versus reduced supply and the circadian variations in ambulatory myocardial ischemia. Therapeutic implications.
    Deedwania PC
    Circulation; 1993 Jul; 88(1):328-31. PubMed ID: 8100490
    [No Abstract]   [Full Text] [Related]  

  • 74. Circadian rhythms and coronary artery disease.
    Rocco MB; Nabel EG; Selwyn AP
    Am J Cardiol; 1987 Mar; 59(7):13C-17C. PubMed ID: 3825926
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Circadian patterns of myocardial ischemia: pathophysiologic and therapeutic considerations.
    Gottlieb SO
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S18-21. PubMed ID: 2467121
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Characteristics and clinical significance of silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with ischemic heart disease].
    Kohya T; Yasuda H
    Nihon Naika Gakkai Zasshi; 1990 Sep; 79(9):1201-3. PubMed ID: 2258667
    [No Abstract]   [Full Text] [Related]  

  • 77. Details of a real world implementation of Fourier techniques for power spectral analysis of heart rate variability.
    Gilham J
    J Electrocardiol; 1992; 25 Suppl():221-3. PubMed ID: 1297701
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Beta-adrenergic blockade hypothesis of asthma.
    Beall GN
    Calif Med; 1970 Jun; 112(6):43. PubMed ID: 18730356
    [No Abstract]   [Full Text] [Related]  

  • 79. Daily life cardiac ischaemia. Should it be treated?
    Bertolet BD; Pepine CJ
    Drugs; 1995 Feb; 49(2):176-95. PubMed ID: 7729326
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differential autonomic mechanisms underlying early morning and daytime transient myocardial ischaemia in patients with stable coronary artery disease.
    van Boven AJ; Brouwer J; Crijns HJ; Haaksma J; Lie KI
    Br Heart J; 1995 Feb; 73(2):134-8. PubMed ID: 7696022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.